Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Tuberous Sclerosis 2

Interventions

Everolimus 12Sirolimus 10Cannabidiol 3ganaxolone 2Melatonin 2Activator Appliances 2radiprodil 1Vigabatrin 1Urination 1Simvastatin 1Propranolol 1Doxycycline 1Calcitriol 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Tuberous Sclerosis × ganaxolone × Clear all
NCT05323734 2025-07-11

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Marinus Pharmaceuticals

Phase 3 Completed
129 enrolled 13 charts

Tuberous Sclerosis

NCT04285346 2023-04-04

TSC

Marinus Pharmaceuticals

Phase 2 Completed
23 enrolled 9 charts

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡